Publications:

Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study.

Leukemia

Bomben, Riccardo R; Rossi, Francesca Maria FM; Vit, Filippo F; Bittolo, Tamara T; Zucchetto, Antonella A; Papotti, Robel R; Tissino, Erika E; Pozzo, Federico F; Degan, Massimo M; Polesel, Jerry J; Bulian, Pietro P; Marasca, Roberto R; Reda, Gianluigi G; Laurenti, Luca L; Olivieri, Jacopo J; Chiarenza, Annalisa A; Laureana, Roberta R; Postorino, Massimiliano M; Del Principe, Maria Ilaria MI; Cuneo, Antonio A; Gentile, Massimo M; Morabito, Fortunato F; Fronza, Gilberto G; Tafuri, Agostino A; Zaja, Francesco F; Foà, Robin R; Di Raimondo, Francesco F; Del Poeta, Giovanni G; Gattei, Valter V

Publication Date: 2023-02-18

Variant appearance in text: TP53: 434del; L145Rfs*25

PubMed Link: 36807650

Variant Present in the following documents:

• 41375_2023_1845_MOESM1_ESM.pdf

View BVdb publication page

Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence.

Scientific Reports

Pasternack, Helen H; Fassunke, Jana J; Plum, Patrick Sven PS; Chon, Seung-Hun SH; Hescheler, Daniel Alexander DA; Gassa, Asmae A; Merkelbach-Bruse, Sabine S; Bruns, Christiane Josephine CJ; Perner, Sven S; Hallek, Michael M; Büttner, Reinhard R; Bollschweiler, Elfriede E; Hölscher, Arnulf Heinrich AH; Quaas, Alexander A; Zander, Thomas T; Weiss, Jonathan J; Alakus, Hakan H

Publication Date: 2018-10-08

Variant appearance in text: TP53: 434delT; L145Rfs*25

PubMed Link: 30297788

Variant Present in the following documents:

• Main text
• 41598_2018_Article_33027.pdf

View BVdb publication page